Time to Detection of Cytomegalovirus (CMV) DNA in Blood Leukocytes Is a Predictor for the Development of CMV Disease in CMV-Seronegative Recipients of Allografts from CMV-Seropositive Donors following Liver Transplantation (original) (raw)

Atypical Presentation of Cytomegalovirus Infection in a Liver Transplant Patient

PRAVEEN SHARMA

Journal of Clinical and Experimental Hepatology, 2011

View PDFchevron_right

Cytomegalovirus infection in transplant recipients

Natalya Maluf

Clinics, 2015

View PDFchevron_right

The Effect of Donor-Recipient Cytomegalovirus Serology on Adult Liver Transplantation: A Single Center Experience

Andreas Tzakis

Transplantation, 2011

View PDFchevron_right

Monitoring levels of human cytomegalovirus DNA in blood after liver transplantation

Emmanuel Drouet

Journal of Clinical Microbiology, 1995

View PDFchevron_right

Late cytomegalovirus disease following liver transplantation

Ahmed Eid

Transplant International, 2003

View PDFchevron_right

Clinical Utility of Cytomegalovirus Viral Load Testing for Predicting CMV Disease in D+/R- Solid Organ Transplant Recipients

Emily Blumberg

American Journal of Transplantation, 2004

View PDFchevron_right

Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy

Manuel Rodríguez-Perálvarez

American Journal of Transplantation, 2012

View PDFchevron_right

Monitoring human cytomegalovirus infection in transplant recipients

B. Fausto

Journal of Clinical Virology, 2008

View PDFchevron_right

Quantitation of Cytomegalovirus In the Blood of Liver Transplant Recipients

Per Stålhandske

Liver …, 1995

View PDFchevron_right

Cytomegalovirus Infection of the Upper Gastrointestinal Tract Before and After Liver Transplantation

John Fung

Transplantation, 1988

View PDFchevron_right

CLINICAL SIGNIFICANCE OF VIRAL LOAD IN THE DIAGNOSIS OF CYTOMEGALOVIRUS DISEASE AFTER LIVER TRANSPLANTATION

Julio Mendez

Transplantation, 1998

View PDFchevron_right

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study

Yvon Lebranchu

Journal of Antimicrobial Chemotherapy, 2010

View PDFchevron_right

Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients

Ellen Holter, M. Degré

Clinical Microbiology and Infection, 2002

View PDFchevron_right

Cytomegalovirus infection: Its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: A single-center experience

Raman Sardana, Subhash Gupta, Kausar Makki

Liver Transplantation, 2012

View PDFchevron_right

Cytomegalovirus detection in transplant patients: comparison of different methods in a prospective survey

Reinhard Zbinden

Journal of Clinical Microbiology, 1991

View PDFchevron_right

Quantitation of cytomegalovirus DNA by the polymerase chain reaction as a predictor of disease in solid organ transplantation

Alessandro Franchello

Journal of Medical Virology, 2004

View PDFchevron_right

CLINICAL UTILITY OF QUANTITATIVE CYTOMEGALOVIRUS VIRAL LOAD DETERMINATION FOR PREDICTING CYTOMEGALOVIRUS DISEASE IN LIVER TRANSPLANT RECIPIENTS1

Mel Krajden, Daniel Gregson

Transplantation, 1999

View PDFchevron_right

Delayed graft function and rejection are risk factors for cytomegalovirus breakthrough infection in kidney transplant recipients

Joke Roodnat

Pharmacological Research, 2021

View PDFchevron_right

Prevention and treatment of cytomegalovirus infection in organ transplant recipients

John J Fung

Transplant Infectious Disease, 1999

View PDFchevron_right

Cytomegalovirus Experience in Pediatric Kidney Transplantation in 26 Years’ Time

Ahmet Keskinoğlu

Transplantation Proceedings, 2020

View PDFchevron_right

Prospective Evaluation of the Clinical Utility of Different Methods for the Detection of Human Cytomegalovirus Disease after Liver Transplantation

Jeroen Eikenboom

American Journal of Transplantation, 2004

View PDFchevron_right

Correlation of cytomegalovirus (CMV) disease severity and mortality with CMV viral burden in CMV-seropositive donor and CMV-seronegative solid organ transplant recipients

Nicholas Lewin-koh

Open Forum Infectious Diseases

View PDFchevron_right

Cytomegalovirus viremia in solid organ transplantation: does the initial viral load correlate with risk factors and outcomes?

Alan Langnas

Clinical Transplantation, 2007

View PDFchevron_right

Quantification of Human Cytomegalovirus DNA in Bone Marrow Transplant Recipients by Real-Time PCR

Michel Barrois, F. Griscelli

Journal of Clinical Microbiology, 2001

View PDFchevron_right

Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients

L. Folgueira

Transplantation proceedings, 2005

View PDFchevron_right

Cytomegalovirus infection in living donor liver transplant recipients significantly impacts the early post-transplant outcome: A single center experience

Prashant Bhangui

Transplant infectious disease : an official journal of the Transplantation Society, 2018

View PDFchevron_right

Monitoring of human cytomegalovirus infection by antigenemia assay in seropositive renal transplant recipients

Gözde ERSOY

International Journal of Infectious Diseases, 2002

View PDFchevron_right

Cytomegalovirus Infection After Intestinal Transplantation in Children

Michael Green

Clinical Infectious Diseases, 1997

View PDFchevron_right

Virologic Suppression Measured by a Cytomegalovirus (CMV) DNA Test Calibrated to the World Health Organization International Standard Is Predictive of CMV Disease Resolution in Transplant Recipients

tri do

Clinical Infectious Diseases, 2013

View PDFchevron_right